Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy
2004
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Extracellular NAD and ATP: Partners in immune cell modulation
2007
CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia.
2015
FIBROSIS OF THE BONE MARROW: CONTENT AND CAUSES
1985
Intracellular degradation of secretion defect‐type mutants of antithrombin is inhibited by proteasomal inhibitors
1997 StandoutNobel
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
2009
Low Molecular Weight Heparin
1997
Sjögren's syndrome
2005 Standout
The treatment of adult idiopathic thrombocytopenic purpura
1987
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
2012 Standout
What is “quality of evidence” and why is it important to clinicians?
2008 Standout
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention
2004
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer
2015
Antithrombotic Therapy for VTE Disease
2016 Standout
A Comparative Study of Interleukin-1β Production and P2x7 Expression After Atp Stimulation by Peripheral Blood Mononuclear Cells Isolated From Rheumatoid Arthritis Patients and Normal Healthy Controls
2007
Heparin-Induced Thrombocytopenia
1998
Slow infusions of vinblastine in the treatment of adult idiopathic thrombocytopenic purpura: A report on 43 cases
1990
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Pathogenesis of myeloma bone disease
2008
Immunogenic cell death in cancer and infectious disease
2016 Standout
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
2006 Standout
Severe Sepsis and Septic Shock
2013 Standout
Myelodysplasia with fibrosis: a distinct entity?
2001
Antithrombotic Therapy for VTE Disease
2012 Standout
Twice vs Three Times Daily Heparin Dosing for Thromboembolism Prophylaxis in the General Medical Population
2007
Hypersensitivity reactions from antineoplastic agents
1987
Immune Thrombocytopenic Purpura
2002 Standout
Heparin-Induced Thrombocytopenia
2006 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Philadelphia Chromosome–Positive Acute Myeloid Leukemia
2007
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
2011 Standout
Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico‐pathological entity
1991
High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults
2004
Prevention of Venous Thromboembolism
2004 Standout
The immunology of stroke: from mechanisms to translation
2011 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
2010
Dapsone for refractory chronic idiopathic thrombocytopenic purpura
1995
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2012
Hypersensitivity reactions from taxol.
1990 Standout
Sterile inflammation: sensing and reacting to damage
2010 Standout
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an eastern cooperative oncology group trial (E4995)
2004
Impaired Platelet Binding of Fibrinogen Due to a Lower Number of GPIIB/IIIA Receptors in Polycythemia Vera
1998 StandoutNobel
A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients
1994
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia
1999
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Grades of Recommendation for Antithrombotic Agents
2008
Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation
2006
Heparin-induced Thrombocytopenia, a Prothrombotic Disease
2007
Long-Term observation of 208 adults with chronic idiopathic thrombocytopenic purpura
1995
Cutaneous Vasculitis in Primary Sjögren Syndrome
2004
Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura
2005
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis
1992
Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone disease
2003
P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation
2007
Maturation of the hemostatic system during childhood
1992 Standout
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study Group
1990
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.
1994 Standout
Antithrombin III Deficiency and Thromboembolism
1981
Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents.
1987
Low Molecular Weight Heparin
1997
Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies
1992
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Glu496 to Ala Polymorphism in the P2X7 Receptor Impairs ATP-Induced IL-1β Release from Human Monocytes
2004
The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide ofStreptococcus pneumoniaein the marginal zone of mouse spleen
2003 StandoutNobel
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Immunological and Inflammatory Functions of the Interleukin-1 Family
2009 Standout
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy
2004
Curcumin: an orally bioavailable blocker of TNF and other pro‐inflammatory biomarkers
2013
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Polycythemia vera: myths, mechanisms, and management
2002
The Inflammasomes: Guardians of the Body
2009 Standout
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Systemic lupus erythematosus and myelofibrosis
1986 StandoutNobel
Multiple Myeloma
2011 Standout
Adjuvant Therapy with Bioavailability‐Boosted Curcuminoids Suppresses Systemic Inflammation and Improves Quality of Life in Patients with Solid Tumors: A Randomized Double‐Blind Placebo‐Controlled Trial
2014
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Exacerbation of Experimental Autoimmune Encephalomyelitis in P2X7R−/− Mice: Evidence for Loss of Apoptotic Activity in Lymphocytes
2006
Surgery of the Spleen
1983
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of A. Manoharan being referenced
The Potential Role of Curcumin in Patients with Monoclonal Gammopathy of Undefined Significance—Its Effect on Paraproteinemia and the Urinary N-Telopeptide of Type I Collagen Bone Turnover Marker
2009
Heparin‐induced thrombocytopenia: cross‐reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran)
1995
Prospective Randomised Open-label Comparison of Danaparoid with Dextran 70 in the Treatment of Heparin-induced Thrombocytopaenia with Thrombosis
2001
Myelofibrosis in primary myelodysplastic syndromes: a clinico‐morphological study of 10 cases
1989
Percutaneous vertebroplasty for acute vertebral body fracture and deformity in multiple myeloma: a short report
2004
Platelet function in myeloproliferative disorders: Characterization and sequential studies show multiple platelet abnormalities, and change with time
1988
A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study
2002
Clinical Annotation. TREATMENT OF REFRACTORY IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS
1991
A Phase I/II Study of Intensive Dose Escalation of Cytarabine in Combination with Idarubicin and Etoposide in Induction and Consolidation Treatment of Adult Acute Myeloid Leukemia
1999
Biochemical, histomorphometric and densitometric changes in patients with multiple myeloma: effects of glucocorticoid therapy and disease activity
1997
Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: A randomized, double‐blind placebo‐controlled cross‐over 4g study and an open‐label 8g extension study
2012
Targeted‐immunosuppression with vincristine infusion in the treatment of immune thrombocytopenia
1991
Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis
1984
ANTITHROMBIN III DEFICIENCY IN AN AUSTRALIAN FAMILY
1980
Non‐Tropical Idiopathic Splenomegaly (Dacie's Syndrome)
1982
A PHASE Ml STUDY OF CYTOSINE ARABINOSIDE, DAUNORUBICIN, AND VP16–213 IN ADULT PATIENTS WITH ACUTE NON‐LYMPHOCYTIC LEUKEMIA
1986
Heparin‐induced skin reaction
1984
Acute Non‐lymphocytic Leukaemia in the Third Trimester of Pregnancy
1979
THE CYTARABINE SYNDROME IN ADULTS
1985
The Reticulin Content of Bone Marrow in Acute Leukaemia in Adults
1979
Slow infusion of vincristine in the treatment of idiopathic thrombocytopenic purpura
1986
Acquired Amegakaryocytic Thrombocytopenia: Report of a Case and Review of Literature
1989
Haematological Manifestations of Primary Sjögren's Syndrome: A Clinicopathological Study
1992